ArticlePloS one2022

Comparative analysis of molecular signatures reveals a hybrid approach in breast cancer: Combining the Nottingham Prognostic Index with gene expressions into a hybrid signature.

Dimitrij Tschodu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.